BACKGROUND Transradial access (TRA) for percutaneous coronary intervention (PCI) reduces complications compared to transfemoral access (TFA). Elderly patients have a higher rate of complications and adverse outcomes after PCI, yet only a few studies have compared the outcomes between both approaches and results have been inconsistent. We aimed to evaluate the efficacy and safety between TRA and TFA in elderly patients 75 year old undergoing PCI.
BACKGROUND Transradial access (TRA) for percutaneous coronary intervention (PCI) reduces complications compared to transfemoral access (TFA). Elderly patients have a higher rate of complications and adverse outcomes after PCI, yet only a few studies have compared the outcomes between both approaches and results have been inconsistent. We aimed to evaluate the efficacy and safety between TRA and TFA in elderly patients 75 year old undergoing PCI.
METHODS We conducted electronic literature search of PubMed CEN-TRAL, EMBASE, The Cochrane Register of Controlled Trials, Google Scholar databases and the scientific session abstracts. The primary efficacy endpoint was major adverse cardiovascular events (MACE), allcause mortality, new myocardial infarction (MI), and length of stay. Safety endpoints included vascular complications, major bleeding, procedure failure, and target vessel revascularization (TVR). Odds ratios (OR) and 95% confidence intervals (CI) were computed using the Mantel-Haenszel (MH) method. Fixed-effect model was used; if heterogeneity (I2)>40, effects were obtained using a random model. CONCLUSIONS Our meta-analysis showed that TRA is associated with favorable outcomes and fewer complications compare to TFA. TRA should be considered as a feasible and safe approach in the elderly population undergoing PCI.
RESULTS
CATEGORIES CORONARY: PCI Outcomes KEYWORDS Elderly, Meta-analysis, Percutaneous coronary intervention
TCT-439
The beneficial effect of percutaneous coronary intervention over optimal medical therapy in elderly patients with angina pectoris; a prospective randomized trial BACKGROUND Compared to medical treatment, clinical benefit of percutaneous coronary intervention (PCI) has not been clearly established in elderly patients with angina pectoris because of increased risk of complications or adverse cardiac events after PCI in elderly patients with higher incidence of multiple comorbidities and fragile physical performance.
METHODS we evaluated the efficacy of elective PCI versus optimal medical treatment (OMT) in elderly patients (age between 75 and 84 years old) with angina pectoris. One-hundred seventy-seven patients with significant coronary artery stenosis were randomly assigned into either the PCI group (n¼90) or the OMT group (n¼87). The primary outcome was a composite of major adverse events which consisted of cardiovascular death, nonfatal myocardial infarction, coronary revascularization or stroke for 1 year follow-up.
RESULTS Major adverse events occurred in 5 patients (5.6%) of the PCI group and 17 patents (19.5%) of the OMT group (p¼0.015). There were no significant differences between the PCI group and the OMT group in cardiac death [hazard ratio (HR) for the PCI group 0.454; 95% confidence interval (CI), 0.041-5.019, p¼0.520], myocardial infarction (HR 0.399; 95% CI, 0.039-4.050, p¼0.437) and stroke (HR 0.919; 95% CI 0.057-14.709, p¼0.952). However, the PCI group showed preventive effect for the coronary revascularization (HR 0.157; 95% CI 0.035-0.703, p¼0.016) and a composite of major adverse events (HR 0.288; 95% CI 0.106-0.785, p¼0.015).
CONCLUSIONS In conclusion, compared to OMT, elective PCI reduced major adverse events and is an effective treatment modality in elderly patients with angina pectoris and significant coronary artery stenosis. BACKGROUND The economic and human burden of Coronary Artery Disease (CAD) is substantial. Although Percutaneous Coronary Intervention (PCI) can reduce the morbidity and mortality associated with CAD, recent clinical trial data indicate that up to a third of patients experience angina in the year after PCI. Given the selective inclusion criteria of most trials, results cannot always be extrapolated to all patients treated. This study aimed to use real-world data to explore the incidence of post PCI angina and chest pain and subsequent costs to secondary care providers in England.
